Zobrazeno 1 - 10
of 689
pro vyhledávání: '"Schmedt N"'
Autor:
Htoo PT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., NajafZadeh M; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Tesfaye H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Wexler DJ; Massachusetts General Hospital Diabetes Center, Harvard Medical School, Boston, MA., Glynn RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Schmedt N; Global Epidemiology, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Déruaz-Luyet A; Global Epidemiology, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Koeneman L; Global Medical Affairs, Lilly Deutschland GmbH, Bad Homburg vor der Höhe, Germany., Paik JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Publikováno v:
Diabetes care [Diabetes Care] 2024 Nov 01; Vol. 47 (11), pp. 1900-1907.
Autor:
Hradetzky, E., Ohlmeier, C., Brinkmann, C., Schild, M., Galetzka, W., Schmedt, N., John, T., Kaleth, D., Gothe, H.
Aim Musculoskeletal disorders are a major public health problem in most developed countries. As a main cause of chronic pain, they have resulted in an increasing prescription of opioids worldwide. With regard to the situation in Germany, this study a
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A91045
https://tud.qucosa.de/api/qucosa%3A91045/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A91045/attachment/ATT-0/
Autor:
Tesfaye H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Wang KM; Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Center for Healthcare Organization & Implementation Research (CHOIR), VA Boston Healthcare System, Boston, MA, USA., Zabotka LE; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Wexler DJ; MGH Diabetes Center, Division of Endocrinology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Schmedt N; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Koeneman L; Lilly Deutschland GmbH, Bad Homburg, Germany., Seman L; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA., Paik JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Center for Healthcare Organization & Implementation Research (CHOIR), VA Boston Healthcare System, Boston, MA, USA., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. epatorno@bwh.harvard.edu.
Publikováno v:
Journal of general internal medicine [J Gen Intern Med] 2024 Aug; Vol. 39 (10), pp. 1870-1879. Date of Electronic Publication: 2024 May 06.
Autor:
Htoo PT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Tesfaye H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Wexler DJ; Massachusetts General Hospital Diabetes Center, Harvard Medical School, Boston, MA, USA., Everett BM; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Glynn RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Schmedt N; Global Epidemiology, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Koeneman L; Global Medical Affairs, Lilly Deutschland GmbH, Bad Homburg vor der Höhe, Germany., Déruaz-Luyet A; Global Epidemiology, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Paik JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Division of Renal (Kidney) Medicine, Brigham and Women's Hospital, Boston, MA, USA., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. epatorno@bwh.harvard.edu.
Publikováno v:
Diabetologia [Diabetologia] 2024 Jul; Vol. 67 (7), pp. 1328-1342. Date of Electronic Publication: 2024 Mar 21.
Autor:
Kreutz R; Charité - Universitätsmedizin Berlin, Institute of Clinical Pharmacology and Toxicology, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: reinhold.kreutz@charite.de., Kloss S; Bayer AG, Müllerstraße 178, 13342 Berlin, Germany., Enders D; InGef - Institute for Applied Health Research Berlin, Spittelmarkt 12, 10117 Berlin, Germany., Abdelgawwad K; Bayer AG, Müllerstraße 178, 13342 Berlin, Germany., Häckl D; University Leipzig, Health Economics and Management, Grimmaische Straße 12, 04109 Leipzig, Germany; WIG2 - Scientific Institute for Health Economics and Health System Research, Markt 8, 04109 Leipzig, Germany., Schmedt N; InGef - Institute for Applied Health Research Berlin, Spittelmarkt 12, 10117 Berlin, Germany., Bonnemeier H; University Medical Center Schleswig-Holstein, Department of Electrophysiology and Rhythmology, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Publikováno v:
International journal of cardiology [Int J Cardiol] 2024 Jun 01; Vol. 404, pp. 131894. Date of Electronic Publication: 2024 Mar 02.
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 15, Pp 1439-1457 (2019)
Alexandra Simbrich,1 Jasmine Thibaut,1 Laura Khil,1,2 Klaus Berger,1 Oliver Riedel,3 Niklas Schmedt3,41Institute of Epidemiology and Social Medicine, University of Münster, 48149 Münster, Germany; 2Cancer Registry North Rhine-Westphalia, 44801, Boc
Externí odkaz:
https://doaj.org/article/963d319a905840299a92bfc98e4d4865
Autor:
Htoo PT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA., Tesfaye H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA., Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA., Wexler DJ; Massachusetts General Hospital Diabetes Center, Harvard Medical School, Boston, USA., Everett BM; Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, USA., Glynn RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA., Schmedt N; Global Epidemiology, Boehringer Ingelheim International GmbH (Germany) DE, Berlin, Germany., Koeneman L; Global Medical Affairs, Lilly Deutschland GmbH, Bad Homburg, Germany., Déruaz-Luyet A; Global Epidemiology, Boehringer Ingelheim International GmbH (Germany) DE, Berlin, Germany., Paik JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA.; Division of Renal (Kidney) Medicine, Brigham and Women's Hospital, Boston, MA, USA., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA. epatorno@bwh.harvard.edu.
Publikováno v:
Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Mar 18; Vol. 23 (1), pp. 103. Date of Electronic Publication: 2024 Mar 18.
Autor:
Htoo PT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA., Tesfaye H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA., Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA., Wexler DJ; Massachusetts General Hospital Diabetes Center, Harvard Medical School, Boston, USA., Everett BM; Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, USA., Glynn RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA., Schmedt N; Global Epidemiology, Boehringer Ingelheim International GmbH (Germany) DE, Berlin, Germany., Koeneman L; Global Medical Affairs, Lilly Deutschland GmbH, Bad Homburg, Germany., Déruaz-Luyet A; Global Epidemiology, Boehringer Ingelheim International GmbH (Germany) DE, Berlin, Germany., Paik JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA.; Division of Renal (Kidney) Medicine, Brigham and Women's Hospital, Boston, MA, USA., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA. epatorno@bwh.harvard.edu.
Publikováno v:
Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Feb 08; Vol. 23 (1), pp. 57. Date of Electronic Publication: 2024 Feb 08.
Publikováno v:
Journal of Public Health (09431853); Mar2022, Vol. 30 Issue 3, p711-720, 10p
Autor:
Folkerts K; Bayer AG, Wuppertal, Germany., Millier A; Creativ-Ceutical, Paris, France., Smela B; Creativ-Ceutical, Cracow, Poland., Olewinska E; Creativ-Ceutical, Cracow, Poland., Schmedt N; Bayer AG, Berlin, Germany., Mernagh P; Bayer AG, Berlin, Germany., Kovesdy CP; Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA. ckovesdy@uthsc.edu.
Publikováno v:
Journal of nephrology [J Nephrol] 2023 May; Vol. 36 (4), pp. 1135-1167. Date of Electronic Publication: 2022 Nov 23.